Ethics of Autonomous AI Clinical Trials: Delphi Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Ethical Considerations in Autonomous AI Clinical Research: Insights from a Delphi Study

  • By

  • Ariadne A Nichol

  • Alaa Youssef

  • David B Larson

  • Michael Abramoff

  • Risa M Wolf

  • Danton Char

  • Nicole Martinez-Martin

  • August 21, 2026

Share

  • 1

    Autonomous AI tools are designed to screen for diseases and generate clinical recommendations without specialist oversight.

  • 2

    The FDA has authorized over 1000 AI medical devices since the first approval in 2018, highlighting the rapid growth of this technology.

  • 3

    Current ethical guidance for AI in healthcare emphasizes accountability, transparency, and bias mitigation but lacks specific direction for clinical trials.

  • 4

    Emanuel et al's seven core ethical principles for clinical research need adaptation for the unique challenges posed by autonomous AI tools.

  • 5

    A Delphi study focused on an AI screening tool for diabetic retinopathy, a major cause of blindness, to explore ethical considerations in AI.

Original Source(s)

Ethics of Autonomous AI Clinical Trials: Delphi Study

  • by Ariadne A Nichol, Alaa Youssef, David B Larson, Michael Abramoff, Risa M Wolf, Danton Char, Nicole Martinez-Martin

  • August 21, 2026

Related Content

DOJ announces first health care company declination

Campus Eye avoided prosecution after voluntarily disclosing misconduct, cooperating with investigators, and remediating the wrongdoing.

Artificial intelligence in ophthalmology: an invisible environmental footprint

GA Treatment Preferences

Survey questions what drives geographic atrophy treatment decisions for clinicians

  • August 4, 2026

  • 4 min